Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses
- 16 April 2008
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 26 (17), 2164-2174
- https://doi.org/10.1016/j.vaccine.2008.01.057
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Attenuated measles virus as a vaccine vectorVaccine, 2007
- Immunological characterizations of the nucleocapsid protein based SARS vaccine candidatesVaccine, 2006
- Live Attenuated Measles Vaccine as a Potential Multivalent Pediatric Vaccination VectorViral Immunology, 2005
- Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding RegionJournal of Virology, 2005
- Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in FerretsJournal of Virology, 2004
- A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in miceInternational Immunology, 2004
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Frequency of Measles Virus-Specific CD4+and CD8+T Cells in Subjects Seronegative or Highly Seropositive for Measles VaccineClinical and Vaccine Immunology, 2003
- Immune Responses to Measles and Mumps Vaccination of Infants at 6, 9, and 12 MonthsThe Journal of Infectious Diseases, 2001